Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive.

The punches keep coming for Novo Nordisk in its bout with Eli Lilly for weight-loss drug supremacy. Why it matters: Novo was the early GLP-1 leader — so dominant that its diabetes drug Ozempic became ...

Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

Vivtex, cofounded by renowned MIT professor Robert Langer, stands to make as much as $2.1 billion if milestones are met.

The failure of its next-generation obesity drug to match Eli Lilly's blockbuster has blown a hole in Novo's post-Ozempic ...

Danish pharma giant Novo Nordisk is to halve the US price of obesity drug Wegovy and slash the price of diabetes treatment Ozempic from next year as competition ramps up with rival drugmaker Eli Lilly ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with schizophrenia spectrum disorders, according to a study published in JAMA ...